A 69-year-old with recurrent CDI after standard therapy presents with another nonsevere recurrence. In addition to antibiotic therapy, which adjunct r...

Question

A 69-year-old with recurrent CDI after standard therapy presents with another nonsevere recurrence. In addition to antibiotic therapy, which adjunct reduces recurrence risk?

Accepted Answer

Bezlotoxumab 10 mg/kg IV single dose

Answer

Probiotics during antibiotics

Answer

Fecal microbiota transplantation as first-line

Answer

Rifaximin taper for 12 weeks

Answer

Cholestyramine with vancomycin

us-abim MCQ (SBA): Recurrent Clostridioides difficile

A 69-year-old with recurrent CDI after standard therapy presents with another nonsevere recurrence. In addition to antibiotic therapy, which adjunct reduces recurrence risk?